
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TLT | TSXV | CAD | Delayed | |
TLTFF | OTC Markets | USD | Delayed | |
TLT | CBOE Canada | CAD | Real-time |
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Roger John Dumoulin-White | - | 2023 | President, CEO & Director |
Randy Bruder | - | 2008 | Independent Director |
Michael A. O'Donnell | - | 2023 | Member of Medical & Scientific Advisory Board |
Kristina Hachey | - | 2004 | CFO & Director |
Matthew Perraton | - | 2013 | Independent Chairman of the Board |
Guy J. Anderson | - | 2013 | Independent Director |
Ashish M. Kamat | - | 2014 | Member of Medical & Scientific Advisory Board |
Arkady Mandel | - | 2011 | Chief Scientific Officer & Director |
Kaouthar Lbiati | 45 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review